V Subbiah

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

V Subbiah
Apr 8, 2025, 03:42 | Insight
Arndt Vogel: Clear guidance to define and improvequality standards for MTBs
Arndt Vogel, Director of the Center for Personalized Medicine at Hannover Medical School, shared a…
Apr 7, 2025, 09:29 | Blog
Giuseppe Curigliano: ESMO Precision Oncology Working Group Quality and Structure Recommendations for MTBs
Giuseppe Curigliano, ESMO President-Elect and Open Editor in Chief, shared a LinkedIn post about recent…
Apr 6, 2025, 13:37 | Insight
Erick Saldanha: The role of ctDNA clearance as a biomarker of neoadjuvant immune checkpoint blockade in solid tumours
Erick Saldanha, Medical Oncologist and Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, shared a…
Feb 20, 2025, 10:45 | Blog
Evaluating molecularly guided therapies beyond tumor type - ESMO
ESMO shared a post on X: "The ESMO Tumor-Agnostic Classifier and Screener (ETAC-S) introduces a…
Dec 19, 2024, 21:11 | Science
Liquid Biopsy Response Evaluation Criteria in Solid Tumor - International Society of Liquid Biopsy
International Society of Liquid Biopsy shared a recent article by Mohamed Alaa Gouda on X:…
Oct 27, 2024, 19:53 | Blog
Andre Fabrice: ESMO Tumor Agnostic Classifier and Screener
Andre Fabrice, Director of the Research Division at Gustave Roussy Cancers Center, shared on X:…
Sep 1, 2024, 16:52 | Blog
Paolo Cotzia about the ESMO Tumor-Agnostic Classifier taxonomy
Paolo Cotzia shared a post on LinkedIn about recently published paper: The ESMO Tumour-Agnostic Classifier…
All: 7 Posts: 1 - 100
Special Coverage